Literature DB >> 18600050

Expression, purification, and characterization of C-terminal amidated glucagon in Streptomyces lividans.

Xiaoqiang Qi1, Rong Jiang, Cheng Yao, Ren Zhang, Yuan Li.   

Abstract

Glucagon, a peptide hormone produced by alpha-cells of Langerhans islets, is a physiological antagonist of insulin and stimulator of its secretion. In order to improve its bioactivity, we modified its structure at the C-terminus by amidation catalyzed by a recombinant amidase in bacterial cells. The human gene coding for glucagon-gly was PCR amplified using three overlapping primers and cloned together with a rat alpha-amidase gene in plasmid pMGA. Both genes were expressed under control of the strong constitutive promoter of aph and secretion signal melC1 in Streptomyces lividans. With Phenyl-Sepharose 6 FF, Q-Sepharose FF, SP-Sepharose FF chromatographies and HPLC, the peptide was purified to about 93.4% purity. The molecular mass of the peptide is 3.494 kDa as analyzed by MALDI TOF, which agrees with the theoretical mass value of the C-terminal amidated glucagon. The N-terminal sequence of the peptide was also determined, confirming its identity with human glucagon at the N-terminal part. ELISA showed that the purified peptide amide is bioactive in reacting with glucagon antibodies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600050

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  3 in total

1.  Production of the catalytic core of human peptidylglycine α-hydroxylating monooxygenase (hPHMcc) in Escherichia coli.

Authors:  Sumit Handa; Tyler J Spradling; Daniel R Dempsey; David J Merkler
Journal:  Protein Expr Purif       Date:  2012-04-25       Impact factor: 1.650

2.  Metabolomics investigation of recombinant mTNFα production in Streptomyces lividans.

Authors:  Howbeer Muhamadali; Yun Xu; David I Ellis; Drupad K Trivedi; Nicholas J W Rattray; Kristel Bernaerts; Royston Goodacre
Journal:  Microb Cell Fact       Date:  2015-10-09       Impact factor: 5.328

3.  Recombinant expression and in vitro characterisation of active Huwentoxin-IV.

Authors:  Isabelle Sermadiras; Jefferson Revell; John E Linley; Alan Sandercock; Peter Ravn
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.